Robert A. Vigersky

Endocrinology

8901 Wisconsin Ave
Bethesda, MD 20889

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Letter: Authors' Response to LTE by Scaramuzza et al.

Letter: Authors' Response to LTE by Scaramuzza et al.

Journal: Diabetes technology & therapeutics

Published: August 20, 2026

Glycemic Concordance of Simplera Sync™ and Instinct™ Sensors in MiniMed™ 780G System Users: A Randomized Crossover Feasibility Study.

Glycemic Concordance of Simplera Sync™ and Instinct™ Sensors in MiniMed™ 780G System Users: A Randomized Crossover Feasibility Study.

Journal: Diabetes technology & therapeutics

Published: May 21, 2026

Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.

Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: April 29, 2026

MiniMed™ 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage.

MiniMed™ 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage.

Journal: Diabetes technology & therapeutics

Published: April 13, 2026

Early Initiation of Automated Insulin Delivery at Type 1 Diabetes Diagnosis in Children and Adolescents Is Associated with Improved Outcomes.

Early Initiation of Automated Insulin Delivery at Type 1 Diabetes Diagnosis in Children and Adolescents Is Associated with Improved Outcomes.

Journal: Diabetes technology & therapeutics

Published: April 08, 2026

Mitigation Strategies for a Missed Meal Bolus in People with Type 1 Diabetes Using the Minimed™ 780G System.

Mitigation Strategies for a Missed Meal Bolus in People with Type 1 Diabetes Using the Minimed™ 780G System.

Journal: Diabetes technology & therapeutics

Published: November 20, 2025

Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.

Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.

Journal: Frontiers in endocrinology

Published: September 30, 2025

Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States.

Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States.

Journal: Diabetes technology & therapeutics

Published: September 16, 2025

Automated insulin delivery with the MiniMed™ 780G system reduces burden by improving sleep and glycaemic control overnight.

Automated insulin delivery with the MiniMed™ 780G system reduces burden by improving sleep and glycaemic control overnight.

Journal: Diabetes, obesity & metabolism

Published: September 03, 2025

MiniMed 780G Advanced Hybrid Closed-Loop System Use During Days Without User-Initiated Boluses.

MiniMed 780G Advanced Hybrid Closed-Loop System Use During Days Without User-Initiated Boluses.

Journal: Diabetes care

Published: August 28, 2025

Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor.

Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor.

Journal: Diabetes technology & therapeutics

Published: August 18, 2025

Registration and Real-Life Studies on Automated Insulin Delivery Systems.

Registration and Real-Life Studies on Automated Insulin Delivery Systems.

Journal: Diabetes technology & therapeutics

Published: July 01, 2025

Showing 1-12 of 100

Last Updated: 09/26/2026